ESR1 and breast carcinoma: To evaluate the impact of Sdc-1 downregulation on HA synthesis and function, we silenced Sdc-1 employing siRNA knockdown (KD) in the breast cancer cell lines MCF-7 (ER+, luminal subtype) and MDA-MB-231 (triple-negative, basal subtype).